Co-inhibitory receptors, including programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4), function as pivotal checkpoints in constraining immune reactions targeting the tumor [33, 34]. Here, CTLA4 is linked to neoplasm.